Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction-Reference-Cited by-同舟云学术

Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction

Published:2016-11-07 Issue: Volume:7 Page:
ISSN:1664-302X
Container-title:Frontiers in Microbiology
language:
Short-container-title:Front. Microbiol.

Author:

Pleet Michelle L.,Mathiesen Allison,DeMarino Catherine,Akpamagbo Yao A.,Barclay Robert A.,Schwab Angela,Iordanskiy Sergey,Sampey Gavin C.,Lepene Benjamin,Ilinykh Philipp A.,Bukreyev Alexander,Nekhai Sergei,Aman M. Javad,Kashanchi Fatah

Funder

National Institutes of Health

U.S. Department of Energy

National Institute of Allergy and Infectious Diseases

Publisher

Frontiers Media SA

Subject

Microbiology (medical),Microbiology

Reference99 articles.

1. Presence of viral RNA and proteins in exosomes from cellular clones resistant to rift valley fever virus infection.;Ahsan;Front. Microbiol.,2016

2. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies.;Akers;J. Neurooncol.,2013

3. Inflammatory responses in Ebola virus-infected patients.;Baize;Clin. Exp. Immunol.,2002

4. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.;Baize;Nat. Med.,1999

5. Apoptosis in fatal Ebola infection. Dose the virus toll the bell for immune system?.;Baize;Apoptosis,2000

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EV71 infection alters the lipid composition of human rhabdomyosarcoma (RD) cells-derived extracellular vesicles;Frontiers in Microbiology;2024-09-05

2. Engineering Exosomes for Therapeutic Applications: Decoding Biogenesis, Content Modification, and Cargo Loading Strategies;International Journal of Nanomedicine;2024-07

3. Ebola virus infection of Flt3-dependent, conventional dendritic cells and antigen cross-presentation leads to high levels of T-cell activation;2024-05-17

4. Autophagy Deregulation in HIV-1-Infected Cells Increases Extracellular Vesicle Release and Contributes to TLR3 Activation;Viruses;2024-04-20

5. Revolutionizing viral disease treatment: Phase separation and lysosome/exosome targeting as new areas and new paradigms for antiviral drug research;Drug Discovery Today;2024-03